Please provide your email address to receive an email when new articles are posted on . A prospective comparative case series of 50 patients implanted bilaterally ...
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its plans to lead a wide-range of informational and peer-to-peer educational programs at the American ...
“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...
Please provide your email address to receive an email when new articles are posted on . Last month, we started a conversation about extended focus IOLs and what makes a patient a good or bad candidate ...
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens (IOL) for cataract patients ...
Key findings from across the 21 scientific presentations on Alcon products will be presented at the meeting, including the soon-to-launch, first non-diffractive extended depth of focus AcrySof® IQ ...
Q: My eyeglasses can be such an inconvenience that I'm considering vision correction surgery. What are some of the options? A: Whether you need lens replacement due to cataracts or simply wish to ...
Alcon Inc. ALC recently introduced the Clareon PanOptix Pro intraocular lens (IOL) for cataract patients in the United States. PanOptix Pro leverages proprietary ENLIGHTEN NXT Optical technology to ...
GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback